Advait Gupta

5682 POSTS
Advait is our expert writer and manager for the Artificial Intelligence category. His passion for AI research and its advancements drives him to deliver in-depth articles that explore the frontiers of this rapidly evolving field. Advait's articles delve into the latest breakthroughs, trends, and ethical considerations, keeping readers at the forefront of AI knowledge.

Exclusive articles:

China’s ChatGPT Opportunists and Grifters are Hard at Work

Discover how Chinese entrepreneurs are using AI-enabled chatbots like ChatGPT to start content businesses and write self-help books, but the real money is in selling a dream. Learn how they're using it to increase work efficiency and make money.

The Evolving Role of CMOs in a Changing Landscape of Marketing and Technology: Insights from Experts on Social Awareness and Innovation

Discover the changing role of chief marketing officers (CMOs) in today's environment of social change, budget constraints, and technological advancements. Learn from top CMOs and a Gartner expert in this Insider article.

Embrace the Future of ChatGPT and Generative AI: IBM and Gartner Leaders Share Why CMOs Need To

Learn why CMOs need to embrace technology such as ChatGPT and generative AI to succeed in marketing. Discover insights from industry leaders at IBM and Gartner.

Being CMO at Indeed: Balancing Complexity and Dreams

Discover the ever-changing landscape of being a CMO in today's world with insights from Indeed's CMO. Learn how to keep up with new challenges and responsibilities.

Top 10 Tools for a Seamless Writing Experience

Discover the top 10 technology tools that can help both students and professionals in crafting their words. Incorporate these digital tools to improve your writing process and ensure originality.

Breaking

Tech Evolution: From Obama’s Optimism to Harris’s Vision

Explore the evolution of tech policy from Obama's optimism to Harris's vision at the Democratic National Convention. What's next for Democrats in tech?

Tonix Pharmaceuticals TNXP Shares Fall 14.61% After Q2 Earnings Report

Tonix Pharmaceuticals TNXP shares decline 14.61% post-Q2 earnings report. Evaluate investment strategy based on company updates and market dynamics.

The Future of Good Jobs: Why College Degrees are Essential through 2031

Discover the future of good jobs through 2031 and why college degrees are essential. Learn more about job projections and AI's influence.

Pioneering Research Uncovers Vital Biomarker for Orbital Inflammation

An in-depth study reveals HLF as a potential biomarker for orbital inflammation, offering new insights for diagnosis and treatment strategies.
spot_imgspot_img